Livzon Mabpharm
2
36M
1
0.18
1
0.50
1
- Areas of investment
Summary
In 2010 was created Livzon Mabpharm, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The main department of described Corporate Investor is located in the Zhuhai.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Therapeutics, Life Science. Among the various public portfolio startups of the fund, we may underline Epirus Biopharmaceuticals Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2005.
The typical case for the fund is to invest in rounds with 8 participants. Despite the Livzon Mabpharm, startups are often financed by Montreux Equity Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Mousse Partners, Montreux Equity Partners.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.18
- Follow on index
- 0.50
- Investments by industry
- Life Science (2)
- Biotechnology (2)
- Therapeutics (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 16 Apr 2014 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 36M | United States, Massachusetts, Boston |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.